The Claim
A 12-week low-carbohydrate energy-restricted diet intervention in adults with type 2 diabetes and obesity reduces hemoglobin A1c by -1.1% and fasting glucose by -2.2 mmol/L, demonstrating significant glycemic improvement alongside medication reduction.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When people with type 2 diabetes and obesity follow a low-carb diet for 12 weeks, their blood sugar levels drop significantly and they may need less medication.
See the scientific wording
A 12-week low-carbohydrate energy-restricted diet in adults with type 2 diabetes and obesity reduces hemoglobin A1c by -1.1% (p=0.007) and fasting glucose by -2.2 mmol/L (p=0.0017), demonstrating significant glycemic improvement alongside medication reduction.
Score breakdown, mechanism chain, raw evidence, ideal studies needed
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.